Raymond Iezzi, MD
Ophthalmology · Rochester, MNNPI 1528006699
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $33,410 of the $43,509 with a category attached, or 76.8%. Johnson & Johnson accounts for 93.3% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2024 at $29,328 and has fallen 78.2% since, to $6,400 in 2025. Among ophthalmology clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 50 payments — averaging $870.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$41K
- Alcon$3K
- Thrombogenics, Inc.$153
- Janssen Global Services, LLC$114
What the payments were for
- Consulting fees$33,41077%
- Travel & lodging$8,31919%
- Food & beverage$1,7814%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 40 | $40,606 |
| Alcon | 7 | $2,636 |
| Thrombogenics, Inc. | 2 | $153 |
| Janssen Global Services, LLC | 1 | $114 |
How this compares
$43,509 in reported general payments places this provider in the 95th percentile of 330 ophthalmology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dorzolamide Hcl | 48 | $789 |
| Latanoprost | 13 | $49 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Rochester
- Sophie BakriRochester$183K
- John ChenRochester$82K
- Arthur SitRochester$33K
- Muhammad BhattiRochester$24K
- Brittni ScruggsRochester$21K
- Sanjay PatelRochester$20K
- Matthew StarrRochester$16K
- Lilly WagnerRochester$15K
- John WoogRochester$6K
- James GarrityRochester$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.